Faricimab May Offer Anatomic Benefits for Patients With DME and Poorer Vision
- Posted on: Aug 16 2024
- Leave a response
In patients with diabetic macular edema (DME) and BCVA of 20/50 or worse, treatment with faricimab may offer better outcomes than aflibercept with significantly fewer injections.
Source: AAO
Posted in: Uncategorized
